查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1138389

全球移植盒市場-2022-2029

Global Transplant Box Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

心血管疾病患病率上升導致市場增長。

根據世界衛生組織的數據，到 2021 年，每年將有 1790 萬人死於心血管疾病。疾病控制和預防中心估計，全世界大約 32% 的死亡是由心血管疾病引起的。在美國，心髒病是人類死亡的第一大原因。在美國，每 34 秒就有一人死於心血管疾病。到 2020 年，美國約有 697,000 人將死於心髒病。冠心病是最常見的心髒病之一，2020年導致382,820人死亡。因此，不斷升級的心血管疾病病例有望增加心臟移植的比例，從而推動移植盒市場的增長。此外，預計肝硬化等慢性肝病患病率的增加將推動預測期內的市場增長。

此外，政府還採取了鼓勵器官捐贈的舉措。政府加大力度促進器官捐贈也是預測期內推動移植盒市場的因素之一。根據 2020 年公佈的全球器官捐贈和移植數據數據庫，2020 年約有 129,681 個器官被移植。在這些器官移植中，腎移植 80,926 例，肝移植 32,586 例，心臟移植 8,101 例，肺移植 5,940 例，胰腺移植 1,970 例，S 腸移植 158 例。

此外，器官移植過程中的技術進步正在促進器官移植，促進市場增長。技術進步是有望加速移植盒市場增長的主要驅動因素。市場參與者不斷努力推出技術先進的設備，以克服移植前器官存活時間短等挑戰。例如，2020 年 3 月，荷蘭生物技術公司 MIMETAS 宣布了 OrganoPlate，這是一種用於芯片上器官的檢測就緒產品系列。它為開發器官模型提供了一個平台，例如腎臟、肝臟、血管、腸道和腦組織。

然而，由於器官移植成本高昂，尋求器官移植的患者數量明顯減少，阻礙了市場增長。此外，器官供需失衡正在阻礙器官移植手術市場。此外，保險實踐中器官移植的不確定報銷方案也限制了預測期內對器官移植免疫抑製劑市場的需求。此外，器官移植的不確定報銷方案也限制了預測期內移植盒市場的狀況。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

  • 按應用劃分的市場細分
  • 按地區劃分的市場細分

第 4 章市場動態

  • 市場影響因素
  • 驅動程序
    • 慢性病高發
    • 增加醫療保健支出
    • 增加有效治療
  • 限制因素
    • 器官移植的高昂費用
  • 商機
  • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 價值鏈分析
  • PEST 分析
  • 定價分析
  • 監管分析
  • 保險報銷分析
  • 未滿足的需求
  • 專利趨勢

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按應用程序

  • 心
  • 肝臟
  • 肺
  • 腎臟
  • 其他

第 8 章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 9 章競爭格局

  • 競爭場景
  • 市場情況/份額分析
  • 併購分析

第 10 章公司簡介

  • HIbernicor
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • OrganOx Limited
  • Institut Georges Lopez-IGL
  • Organ Recovery Systems, Inc.
  • Paragonix Technologies, Inc.
  • XVIVO Perfusion AB
  • Transmedics, Inc.
  • Other Companies

第11章 DataM

簡介目錄
Product Code: DMHCIT3039

Market Overview

Transplant Box Market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 8.2 % during the forecast period (2022-2029).

Transplant box technology is an experimental organ transplant and preservation system. It lets the donor organ continue functioning outside the body while transporting it. The transplant box keeps the heart healthy and safe by protecting it in an environment similar to conditions inside the body, which includes the delivery of warmth and nourishment by blood and oxygen. The transplant box technology improves tissue matching between recipients and donors, as the box allows more time to test the organ for potential rejection factors. The package could help grow the donor pool by allowing the donor organ to be safely transported over longer distances. Rising cases of multiple organ failure across the globe, especially in developed economies, coupled with an increasingly geriatric population, are the major factors driving the transplant box market's growth.

Market Dynamics: The growing prevalence of cardiovascular disease leads to the market's growth.

According to World Health Organization data, 17.9 million people died annually from cardiovascular disease in 2021. The Centre for disease prevention estimated that around 32% of deaths worldwide are due to cardiovascular disease. In the United States, heart disease is the leading cause of human death. One person dies every 34 seconds in the United States from cardiovascular disease. About 697,000 people in the United States died from heart disease in 2020. Coronary heart disease is one of the most common types of heart disease, killing 382,820 people in 2020. Thus, escalating cardiovascular disease cases are anticipated to raise the rate of heart transplants, thereby propelling the growth of the transplant box market. Furthermore, the increasing prevalence rate of chronic liver ailments such as liver cirrhosis is expected to boost market growth over the forecast period.

Moreover, Government initiatives to encourage organ donation. The rise in government initiatives to promote organ donation is another factor anticipated to propel the transplant box market during the forecast period. According to the global database on donation and transplantation data published in 2020, around 129681 organs were transplanted in the year 2020. Among these organ transplants, 80,926 are kidney transplants, 32,586 are liver transplants, 8,101 are heart transplants, 5,940 are lung transplants, and 1,970 are pancreas transplants and 158 S. Bowel transplants.

In addition, technological advancement in the organ transplant process drives organ transplants, thereby aiding the market's growth. Technological advancements are a major driver expected to accelerate the growth of the transplant box market. Market players always strive to introduce technologically advanced devices to overcome challenges, including the short duration of organ survival before transplantation. For instance, in March 2020, a Dutch biotech company, MIMETAS, introduced assay ready product line for organ-on-a-chip, OrganoPlate. It provides a platform for developing organ models, such as kidneys, liver, blood vessels, gut, and brain tissues.

However, the high cost associated with organ transplantations significantly reduces the number of patients opting for the design, thereby hampering the market's growth. Additionally, the disproportion in the supply and demand for organs hampering the organ transplant procedures market. Moreover, the uncertain reimbursement scenario of organ transplants in the insurance process also restricts the need for organ transplant immunosuppressant drugs market during the forecast period. Moreover, organ transplants' uncertain reimbursement scenario also limits the condition of the transplant box market during the forecast period.

Market Segmentation: Kidney segment accounted for the highest share in transplant box market.

The kidney segment is anticipated to experience a significant growth rate in the transplant box market. For instance, According to Organ Donation Statistics, in 2020, there were 80,926 kidney transplants done which was 31.70% of total transplants done globally. There 55258 kidney transplants were done from deceased donors, and 25668 kidney transplants were done from living donors. Kidney transplantation or dialysis is the only treatment option to keep a patient alive. Thus, the demand for transplant boxes is expected to surge shortly. Therefore, the need for transplant boxes in kidney transplantation is estimated to contribute interestingly to the market's growth across the globe.

Geographical Penetration: North America is the dominating region during the forecast period.

The North American market leads with the largest market share in the global transplant box market during the forecast period. A technologically advanced healthcare infrastructure drives the growth in the U.S. This, in turn, has led to a rise in the number of transplants, thereby boosting the market share in the region. Moreover, the high investment in advanced technologies in the US healthcare sector is further expected to escalate the region's market growth during the forecast period.

Furthermore, the Asia Pacific region is expected to grow at the highest CAGR globally, owing to a considerable rise in healthcare spending to establish developed healthcare infrastructure in the area. The rising geriatric population and the increase in medical tourism due to the low cost of surgical procedures contribute to the growth of the area's market. The increase in the number of chronic diseases in the area is further contributing to the development of the transplant box market in the area.

Competitive Landscape:

The transplant box market is dominated by a few companies. Some key players in the market's growth include HIbernicor, Organix Limited, Institut Georges Lopez-IGL, Organ Recovery Systems, Inc., Paragonix Technologies, Inc., XVIVO Perfusion AB, Transmedics, Inc., and TeamBest, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the transplant box market growth globally. For instance, in March 2020, Paragonix Technologies, Inc. announced that AdventHealth, a non-profit healthcare service provider in Florida, had given the nod for using its Paragonix SherpaPak CTS to preserve donors' hearts meant for transplantation. In May 2022, OrganOx, a world leader in normothermic machine perfusion (NMP), announced a partnership with Ochre Bio for chronic liver diseases. In December 2021, OrganOx announced that it got FDA approval for its metra normothermic machine perfusion (NMP) system. This device is mostly used to preserve and transport donor livers set for transplantation. The transportable device sustains donor livers in a functioning state for up to 12 hours, mimicking the environment of the human body with warm, oxygenated blood and nutrients between donation and transplantation. In August 2021, Paragonix Technologies Announced the Launch of the New OPTION On-Demand Preservation Services Network in the United States. Due to increased product demands and the need for quick service, Paragonix launched this just-in-time service to ensure the 24/7 availability of Paragonix organ preservation products.

COVID-19 Impact: Positive impact on the transplant box market.

The transplant box depends on the number of new heart diseases, lung diseases, and others. The COVID-19 pandemic has negatively impacted the growth of the market due to the decline in the number of diagnostic procedures, which has decreased the number of new cases of diseases and, ultimately, the demand for transplant boxes across the globe. Moreover, people have avoided hospital visits to contain COVID-19. Furthermore, the deviation in the development of the COVID-19 vaccine in the research institutes and pharmaceutical companies and the R&D in technologically advanced transplant boxes declined in 2020. Therefore, the transplant box market will witness a downfall in market revenue in 2020 and subsequent years.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Application
  • 3.2. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. The high incidence rate of chronic diseases
    • 4.2.2. Improved spending on healthcare
    • 4.2.3. The rise in the availability of effective treatment methods
  • 4.3. Restraints:
    • 4.3.1. The high cost of organ transplant procedures
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 7.1.2. Market Attractiveness Index, By Application Segment
  • 7.2. Heart
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Liver
  • 7.4. Lung
  • 7.5. Kidney
  • 7.6. Others

8. By Region

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 8.3. Market Attractiveness Index, By Region
  • 8.4. North America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.4.4.1. The U.S.
      • 8.4.4.2. Canada
      • 8.4.4.3. Mexico
  • 8.5. Europe
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.5.4.1. Germany
      • 8.5.4.2. The U.K.
      • 8.5.4.3. France
      • 8.5.4.4. Italy
      • 8.5.4.5. Spain
      • 8.5.4.6. Rest of Europe
  • 8.6. South America
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.6.4.1. Brazil
      • 8.6.4.2. Argentina
      • 8.6.4.3. Rest of South America
  • 8.7. Asia Pacific
    • 8.7.1. Introduction
    • 8.7.2. Key Region-Specific Dynamics
    • 8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 8.7.4.1. China
      • 8.7.4.2. India
      • 8.7.4.3. Japan
      • 8.7.4.4. Australia
      • 8.7.4.5. Rest of Asia Pacific
  • 8.8. The Middle East and Africa
    • 8.8.1. Introduction
    • 8.8.2. Key Region-Specific Dynamics
    • 8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

9. Competitive Landscape

  • 9.1. Competitive Scenario
  • 9.2. Market Positioning/Share Analysis
  • 9.3. Mergers and Acquisitions Analysis

10. Company Profiles

  • 10.1. HIbernicor*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Key Highlights
    • 10.1.4. Financial Overview
  • 10.2. OrganOx Limited
  • 10.3. Institut Georges Lopez-IGL
  • 10.4. Organ Recovery Systems, Inc.
  • 10.5. Paragonix Technologies, Inc.
  • 10.6. XVIVO Perfusion AB
  • 10.7. Transmedics, Inc.
  • 10.8. Other Companies

11. DataM Intelligence

  • 11.1. Appendix
  • 11.2. About Us and Services
  • 11.3. Contact Us